NCT02274610View on ClinicalTrials.gov

Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Solid Tumor
Interventions
DRUG

Docetaxel-PNP

Docetaxel Polymeric Nanoparticle Formulation

DRUG

Taxotere

Docetaxel

All Listed Sponsors
lead

Samyang Biopharmaceuticals Corporation

INDUSTRY

NCT02274610 - Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer | Biotech Hunter | Biotech Hunter